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Abstract
Objective—To provide an update on respiratory diseases caused by coal mine dust.
Methods—This article presents the results of a literature review initially performed for an 
International Conference on Occupational and Environmental Lung Disease held in summer 2013.
Results—Coal mine dust causes a spectrum of lung diseases collectively termed coal mine dust 
lung disease (CMDLD). These include Coal Workers’ Pneumoconiosis, silicosis, mixed dust 
pneumoconiosis, dust-related diffuse fibrosis (which can be mistaken for idiopathic pulmonary 
fibrosis), and chronic obstructive pulmonary disease. CMDLD continues to be a problem in the 
United States, particularly in the central Appalachian region. Treatment of CMDLD is 
symptomatic. Those with end-stage disease are candidates for lung transplantation. Because 
CMDLD cannot be cured, prevention is critical.
Conclusions—Coal mine dust remains a relevant occupational hazard and miners remain at risk 
for CMDLD.
Coal is an important global commodity and will remain so for the foreseeable future. Thus, 
mining of coal will also remain important. Despite improvements in exposure assessment 
and ventilation controls and the existence of protective government regulations, coal miners 
are still at risk for respiratory diseases caused by coal mine dust and their associated 
morbidity and mortality. Thus, clinicians must be prepared to diagnose these diseases and 
recognize their association with work in coal mining. This review provides background 
information such as where coal is mined and projected trends in production. It also describes 
respiratory conditions caused by coal mine dust, burden, and risk factors, and covers some 
aspects of diagnosis, treatment, and disease prevention.
GLOBAL COAL PRODUCTION
Despite controversies over greenhouse gases and competition from other energy sources 
such as natural gas extracted by hydraulic fracturing, coal remains the second largest energy 
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source worldwide. Approximately 8 billion short tons were produced in 2010.1 Coal 
contributes about one-fourth of the world’s energy supply and more than one-third of the 
fuel used to generate electricity. Internationally, coal consumption has steadily increased 
since 2000, driven largely by increased demand in China and India.2 In 2010, China (47%), 
the United States (14%), and India (9%) accounted for 70% of world coal consumption. It is 
predicted that the share of consumption by these 3 countries will rise to 75% in 2040. 
Through 2040, worldwide consumption will rise at a rate of 1.8% annually (Fig. 1).1
Coal production in the United States is largely concentrated in a few states, with five 
accounting for 72% of production in 2011: Wyoming (40%), West Virginia (12.3%), 
Kentucky (9.9%), Pennsylvania (5.4%), and Texas (4.2%).2 Coal can be obtained by 
underground mining (primarily in the Eastern United States) or surface mining (dominant in 
the Western United States). Types of coal also vary by region. Anthracite coal (hard coal, 
highest rank), typically used in metallurgy and domestic heating, is limited geographically 
mainly to Appalachia and Pennsylvania. Bituminous coal (soft coal, lower ranked), typically 
used for electric power generation and coke for steel making, is the most abundant type of 
coal found in the United States and found primarily in Appalachia and in Midwestern states 
such as Illinois. Subbituminous coal (still lower ranked than bituminous), typically used in 
electric power generation and heating, is primarily found in Montana, Wyoming, Colorado, 
New Mexico, Washington, and Alaska. It is the most produced type of coal in the United 
States, accounting for 47% of coal production in 2011. Over the past several decades, there 
has been a shift from underground, bituminous coal production in the Eastern United States 
to surface, subbituminous coal production in the Western United States. Western coal 
production currently accounts for 58% of US coal production and is anticipated to reach 
68% by 2040.
RESPIRATORY DISEASES ARE CAUSED BY INHALING COAL MINE DUST
Inhalation of coal mine dust is known to cause several types of respiratory disease. To 
emphasize that there is a spectrum, these have recently been termed “coal mine dust lung 
disease” (CMDLD).3 Classic coal workers’ pneumoconiosis (CWP) and silicosis are the 
diseases most familiar to many. They have similar radiographic findings, with milder forms 
characterized by small (<1 cm) rounded opacities found more in the upper lung zones. A 
more severe form called progressive massive fibrosis (PMF) is characterized by coalescence 
of small opacities into large (≥1 cm) opacities. These diseases can be distinguished by 
pathology; their pathogenesis and pathology are reviewed elsewhere.3 Miners with 
combined exposures to coal and crystalline silica (quartz) dusts can also get mixed dust 
pneumoconiosis. Coal miners with rheumatoid arthritis and a background of 
pneumoconiosis are also at risk for rheumatoid pneumoconiosis, also known as Caplan 
syndrome. In this condition, multiple well-defined rounded nodules, classically resembling 
rheumatoid nodules in other locations, may occur in crops. They range in diameter from 
about 0.5 to several centimeters and are found predominantly at the lung periphery. The 
nodules often cavitate or calcify.4
A source of confusion around the term “CWP” is that in the United States, it has different 
meanings in clinical and statutory/legal settings. Clinically, CWP is generally referred to as 
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interstitial disease caused by inhalation of coal mine dust. Nevertheless, 30 U.S.C. §902(b) 
defines pneumoconiosis in the context of coal mining as a chronic dust disease of the lung 
and its sequelae, including respiratory and pulmonary impairments, arising out of coal mine 
employment. Thus, in legal and compensation settings, “legal pneumoconiosis” includes 
conditions other than interstitial disease, including airways diseases such as chronic 
obstructive pulmonary disease (COPD). In this review, “CWP” is used narrowly in the 
clinical sense. The new term CMDLD is used to describe the spectrum of disease caused by 
coal mine dust.
In addition to the interstitial disease presentations classically associated with coal mining, 
coal miners are also at risk for dust-related diffuse fibrosis (DDF) and chronic airways 
diseases including emphysema and chronic bronchitis. All of these fall within the spectrum 
of CMDLD. The DDF is a form of interstitial disease occurring in coal miners that has a 
radiographic appearance of irregular opacities and can be mistaken for idiopathic pulmonary 
fibrosis (IPF) if an exposure history is not obtained.3 The occurrence of irregular opacities in 
coal miners has long been recognized.5–8 A recent evaluation of 30 years’ experience in the 
US Coal Workers’ Health Surveillance Program (CWHSP) showed that about 38% of coal 
miners with radiographic findings of interstitial disease had primarily irregular opacities. 
These miners showed a lower zone predominance (upper 20.5%, middle 38.4%, and lower 
41.1%).9 A French series of coal miners evaluated for features of chronic interstitial 
pneumonia with honeycombing described lung pathology in eight cases. Two cases showed 
homogeneous interstitial fibrosis without temporal variation and with honeycombing. Six 
cases showed features of usual interstitial pneumonia.10
The DDF seems to occur much more frequently in long-tenured coal miners than IPF does in 
the general population. The prevalence rate per 100,000 in the US general population of IPF, 
defined by the use of the International Classification of Diseases, 9th revision, Clinical 
Modification [ICD-9-CM] code 516.3 in medical claims, has recently been estimated for US 
males at various ages. Rates per 100,000 were 3.8 at 18 to 34 years, 4.9 at 35 to 44 years, 
23.3 at 45 to 54 years, 62.8 at 55 to 64 years, 148.5 at 65 to 74 years, and 276.9 at 75 or 
more years.11 Based on the prevalence data shown in Fig. 2, about 7% of long-tenured US 
coal miners participating in the CWHSP who have 25 or more years’ tenure are found to 
have radiographic changes consistent with CWP. As previously noted, about 38% of these 
long-tenured miners with radiographic changes, or about 2.7% (2700 per 100,000) of this 
long-tenured group, would be expected to primarily have irregular opacities. Thus, 
interstitial lung disease associated with irregular opacities suggestive of DDF is found 
considerably more frequently in long-tenured coal miners than IPF is found in the general 
population. This is true even among older age groups.
It has been recognized for decades that coal mine dust exposure can cause COPD.3,12 Recent 
studies have added to the strength of evidence. For example, a study of 722 autopsied coal 
miners and nonminers in the United States showed that cumulative dust exposure was a 
significant predictor of pathological emphysema severity and had a similar additive effect on 
emphysema severity as smoking.13 In a prospective study following 260 newly hired 
Chinese coal miners, 48 developed bronchitic symptoms, which were associated with a 
sharp early decline in forced expiratory volume in 1 second (FEV1).14 The FEV1 decline 
Laney and Weissman Page 3













over the first 3 years of employment was nonlinear, with a sharp decline in the first year and 
plateauing or even recovery thereafter.15 An analysis of underground coal miners’ 
surveillance data from the CWHSP showed that abnormal spirometry in coal miners was 
associated with radiographic evidence of CWP. Also, these two health outcomes had similar 
geographic distributions. The overall prevalence of lung function impairment was 13.1% in 
actively working underground coal miner participants.16
BURDEN AND RISK FACTORS FOR CWP
The National Institute for Occupational Safety and Health (NIOSH) has operated the 
CWHSP and tracked the burden of CWP in underground coal miners since 1970. For the 
purposes of the CWHSP, CWP is defined as a final determination of small opacities on a 
chest radiograph of a profusion of 1/0 or greater, or any large opacity, using the International 
Labor Office classification system.17 Detailed descriptions of the CWHSP methods are 
available elsewhere.18,19 As shown in Fig. 2, the prevalence of CWP declined after 
implementation of the 1969 Federal Coal Mine Health and Safety Act, which put into place 
regulations to protect coal miners. The prevalence of the most severe form of CWP, PMF, 
reached a low of 0.08% of miners surveyed for the period 1995 to 2000. Nevertheless, since 
2000, rates of CWP have increased and most troubling is the increase in severity. For 
example, in West Virginia alone, 138 miners with PMF were approved for compensation 
between 2000 and 2009. Their mean age was only 52.6 years.20 The most up-to-date data for 
percentage of underground coal miners participating in CWHSP found to have radiographic 
evidence of CWP are presented in Fig. 2. It suggests that after a nadir in the mid- to late 
1990s, prevalence of CWP subsequently increased among CWHSP participants with 15 or 
more years of tenure in underground coal mining. Data from the CWHSP have also 
demonstrated geographical clustering of disease and rapid disease progression,21 increased 
prevalence of radiographic abnormalities suggestive of silicosis,22,23 and associations 
between disease prevalence and small mine size24–26 during this same period. A subsequent 
analysis of potential sources of bias in CWHSP data suggested that the finding of an 
increase in CWP in underground coal miners since 2000 was broadly accurate.27
As already noted, the CWHSP has previously been limited to underground coal miners. 
Thus, less data exists documenting the burden of pneumoconiosis in US surface miners. 
Still, it is well known that surface miners are at risk for pneumoconiosis. In 1983, a sentinel 
case of acute silicosis was reported in a surface coal mine driller.28 The case report included 
reanalysis of surveillance conducted in US surface coal miners in the early 1970s showing 
that drill crew workers were at significantly increased risk for pneumoconiosis relative to 
other surface coal miners. Medical examinations of surface coal miners in Pennsylvania 
conducted in 1984 to 1985 documented radiographic evidence of pneumoconiosis in 4.5% of 
men with no history of dusty work other than surface coal mining. Drilling work was a risk 
factor for the presence and severity of pneumoconiotic disease.29 More contemporary 
national surveillance of surface coal miners conducted across the United States in 2010 to 
2011 documented radiographic evidence of pneumoconiosis in 2% and PMF in 0.5%. 
Miners from Central Appalachia had substantially higher rates of pneumoconiosis (3.7%) 
and PMF (1.2%) than miners from other parts of the country.30
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Years of potential life lost (YPLL) is a measure of premature mortality based on the Centers 
for Disease Control and Prevention’s National Center for Health Statistics (NCHS) multiple 
cause-of-death data files. It is influenced by the number of people dying of a disease and 
their age at death, because death of a younger person results in a greater YPLL than death of 
an older person. The annual trend in YPLL is similar to the trends in CWP prevalence. It 
shows a decline from the 1970s through 2000 and a subsequent increase since that period. 
As shown in Fig. 3, in 2010, mortality from CWP led to an average 8.2 YPLL among 
decedents of CWP (data updated from 2009 MMWR).31
A 2011 review by NIOSH summarized current trends.32 It found that those surveillance data 
indicated that the prevalence of CWP was rising and that coal miners were developing 
severe CWP at relatively young ages (<50 years). The increase in CWP was especially 
concentrated in the central Appalachian region of southern West Virginia, eastern Kentucky, 
and western Virginia. Multiple factors were felt to potentially be causative, including 
excessive coal mine dust levels, increased duration of exposure (due to longer working 
hours), and potentially increased crystalline silica exposure due to the need to cut rock to 
mine thinner coal seams. Workers in smaller mines appeared to be at special risk.
DIAGNOSIS OF CMDLD
Diagnosis of CMDLD-related interstitial disease has recently been reviewed.3 Diagnosis can 
generally be made clinically, on the basis of a combination of an appropriate exposure 
history, radiological or pathological findings consistent with the diagnosis, and a lack of 
alternative explanations for the patient’s lung disease. The exposure history can explore 
intensity of exposure by asking about high-exposure jobs, especially working near the face 
in underground mines or near drilling operations in surface mines. Duration of exposure is 
also important, because cumulative exposure is what is most related to risk of disease. In 
general, pneumoconiosis typically takes at least 10 years after initial exposure to develop in 
the United States. It is important to ask about jobs associated with silica exposure, generally 
from generating quartz dust through activities such as cutting or drilling rock. Examples 
include roof bolting in underground mines and drilling in surface mines.
With regard to chest imaging, it is important to remember that not all patients have “classic 
patterns” of simple pneumoconiosis (small rounded opacities, upper zone predominance) or 
of PMF.
As previously described, distribution across multiple lung zones or lower zone 
predominance and irregular small opacities are not uncommon. High-resolution computed 
tomographic scans of the chest are more sensitive in identifying small and large opacities in 
those with a history of coal mine dust exposure than plain chest images. High-resolution 
computed tomographic scans are most useful in assessment of symptomatic patients and 
those with borderline or atypical radiographic findings.
It is important to rule out other causes for patients’ lung disease, especially if there has been 
less than 10 years of exposure to coal mine dust. Differential diagnoses include 
mycobacterial infection, silica-associated granulomatosis with polyangiitis, and other 
interstitial pneumonias.
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If a patient has had at least 10 years’ of exposure to coal mine dust and has a clinical 
appearance typical for CWP, biopsy is not typically needed for diagnosis. Bilateral 
symmetrical elongated mass lesions in those with advanced CWP are only rarely malignant. 
If there is concern about malignancy based on clinical symptoms or in the setting of a 
unilateral large opacity, a positive positron emission tomography scan is of uncertain 
significance, because PMF lesions are often metabolically active and show uptake 
suggestive of malignancy. In this type of setting, a biopsy may be needed to resolve 
diagnostic uncertainty.
Patients should undergo pulmonary function testing at baseline and in follow-up to 
document level of impairment and to track progression over time. Pulmonary function 
testing also plays an important role in assessment for CMDLD-related airways disease in 
those with substantial exposure histories.
TREATMENT OF CMDLD
There is no specific curative treatment for CWP or other types of CMDLD.3 Ideally, 
additional exposure should be limited. This may be difficult for patients without alternative 
means of support, who may not wish to change their occupations or for their employers to 
become aware of their health status. Patients should be seen periodically to evaluate for 
progression and to provide symptomatic support. Complications such as airflow obstruction, 
respiratory tract infection, respiratory failure/ hypoxemia, cor pulmonale, arrhythmias, and 
pneumothorax may occur. If there has been significant crystalline silica exposure, clinicians 
should be alert to the possibility of Mycobacterial infection as a complication. Supportive 
treatment also includes good general respiratory care. Patients should receive influenza and 
pneumococcal vaccinations as appropriate. They should also be asked about tobacco use at 
every clinic visit and those who are tobacco users urged to quit. Those willing to make a quit 
attempt should be assisted in doing so.33
Lung transplantation has been used in the setting of end-stage disease. Lung transplantation 
for occupational lung disease has historically been rare. In fact, the first case of lung 
transplantation for CWP in the United States documented in United Network of Organ 
Sharing data was reported in 1996.34 Two reports published in 2012 evaluating lung 
transplantation for CWP reported somewhat different results. The experience in 143 patients 
undergoing unilateral or bilateral lung transplantation at the University of Kentucky was of 
generally good outcomes and comparable survivability versus other medical conditions.35 In 
contrast, other investigators observed shorter lung graft survivability compared with 
transplants for COPD, IPF, and silicosis.36 Nevertheless, given the lack of other options for 
miners with CWP and end-stage lung disease, those caring for such miners who are 
appropriate candidates for transplantation should consider referring them for transplant 
evaluation.
PREVENTION OF CMDLD
Because CMDLD cannot be cured, the best way to control it is through prevention. NIOSH 
has provided comprehensive recommendations for prevention.32,37 The most important 
prevention measures are in the workplace and thus not under the control of the clinician. 
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NIOSH recommends limiting exposures to respirable coal mine dust to 1 mg/m3, and to 
respirable crystalline silica to 0.05 mg/m3, as time-weighted average concentrations for up 
to a 10-hour day during a 40-hour work week. Worker exposures should be kept as far 
below these recommended exposure limits as feasible through the use of engineering 
controls and work practices. It is also important to frequently monitor worker exposures so 
interventions can be made if overexposures are detected. In this regard, NIOSH has worked 
with partners to develop and implement the use of a real-time personal respirable dust 
monitor in coal mines.38 The personal respirable dust monitor allows miners to monitor the 
concentration of respirable dust in their breathing zone, allowing the individual to know if 
and when overexposure is occurring. This feedback can lead to immediate corrective action 
to reduce the exposure source or timely removal of the miner from excessive exposures.
Clinicians may become involved in another aspect of a comprehensive prevention program, 
medical screening, and surveillance. Medical screening can benefit the screened coal miner 
if CMDLD is detected early and interventions are made to prevent progression by limiting 
further exposure. This is called secondary prevention. Medical screening can also benefit 
others in the screened population if evaluation of population health data shows particular 
jobs or work areas as trouble spots and interventions are made to correct exposures before 
they cause health effects in additional workers. This is called primary prevention.
NIOSH recommends the following program of medical surveillance for coal miners37:
• A spirometric examination and plain chest radiograph as soon as possible after 
beginning employment (“preplacement,” within 3 months for spirometric 
examination and within 3 to 6 months for chest radiograph).
• A spirometric examination each year for the first 3 years of coal mining and every 
2 to 3 years after that if the miner remains engaged in coal mining.
• A chest radiograph every 4 to 5 years for the first 15 years of coal mining and every 
3 years after that if the miner remains engaged in coal mining.
• A chest radiograph and spirometric examination at the end of employment in coal 
mining if more than 6 months have passed since the last examination.
• A standardized respiratory symptom questionnaire and a standardized occupational 
history questionnaire administered at the first examination and updated at each 
subsequent periodic examination.
• In addition to the above NIOSH recommendations, the World Health Organization 
recommends, “Ideally, health surveillance, particularly for workers exposed to 
silica dust, should be lifelong.”39(p32)
As previously noted in the section on treatment, miners should be asked at each examination 
about tobacco use and those who are tobacco users urged to quit. Those willing to make a 
quit attempt should be assisted in doing so.33 Spirometry should be interpreted consistent 
with international standards.40,41 Chest radiographs should be classified according to the 
International Labour Organization classification and a small opacity profusion of 1/0 or 
greater or the presence of large opacities viewed as suggestive of pneumoconiosis.17 Miners 
should be notified in a timely manner about the results of their examinations, including 
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whether or not any abnormalities were detected. Appropriate medical counseling and 
counseling about any legal implications of findings should be provided. In addition, 
aggregate data from the screened population should be analyzed and reviewed regularly to 
identify trouble spots where improvements in primary prevention are needed to better 
protect miners.
CONCLUSION
Coal continues to be an important global commodity and mining it will continue to be an 
important activity for the foreseeable future. In the United States, coal mining in the East is 
characterized by more underground mining of bituminous coal and in the West by more 
surface mining of subbituminous coal. Exposure to coal mine dust during mining can cause 
a spectrum of disease termed CMDLD. This spectrum includes classic forms of CWP and 
silicosis, mixed dust pneumoconiosis, DDF (which can be mistaken for IPF), and chronic 
obstructive airways disease, including emphysema and chronic bronchitis. In recent years, 
the United States has seen an increasing burden of CMDLD-interstitial diseases, particularly 
in the central Appalachian region. Those affected have included younger miners younger 
than 50 years with severe disease. Proposed explanations include increased levels and 
duration of dust exposure, increased silica content of dust, and issues related to working in 
smaller operations. Because CMDLD can only be treated symptomatically, prevention is 
critical. Clinicians may be called upon to participate in medical screening and surveillance 
programs, which are a part of comprehensive prevention programs. Data from medical 
screening can be useful for both primary and secondary preventions.
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World coal consumption, 2010–2040. From US Energy Information Administration.1
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Percentage of examined US underground miners with coal workers’ pneumoconiosis (ILO 
category 1/0+), 1970–2012. Data are shown as 5-year moving average, with separate plots 
for various tenures in coal mining. Data are from NIOSH CWHSP.19
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Years of potential life lost (YPLL) before the age of 65 years and mean YPLL per decedent 
for decedents 25 years or older with coal workers’ pneumoconiosis as the underlying cause 
of death—United States, 1968–2010. Based on annual underlying cause of death from 
multiple cause-of-death files, National Center for Health Statistics, Centers for Disease 
Control and Prevention (updated from figure in Amandus et al29).
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